Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Verduyn

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology in Drug Development|October 27, 2022
Safety, Pharmacokinetics, and Biomarkers of an Amorphous Solid Dispersion of Genistein, a Radioprotectant, in Healthy VolunteersArtur A Serebrenik, Carin W Verduyn, Michael D Kaytor
Human Immunology|February 1, 1995
Novel HLA-DPB1 alleles detected in the Ethiopian populationL F Versluis, W Verduyn, J Abdulkadir, et al.
Human Immunology|March 1, 1996
Sequence of HLA-DRB 1*1606 is incorrectJ D Anholts, A G Bouwens, W Verduyn, et al.
Human Immunology|April 1, 1992
T-cell recognition of class II products that result from the combined presence of two different HLA haplotypesW E Schroeijers, H S de Koster, W Verduyn, et al.
Human Immunology|June 1, 1994
Polymorphic gloves and histocompatibility testingJ J Drabbels, J Anholts, M J Giphart, et al.
Tissue Antigens|September 12, 2009
Thirty-six novel HLA alleles: 7 HLA-A, 11 HLA-B, 15 HLA-C and 3 HLA-DRB1J D H Anholts, M Aneq, H L J M Dirks, et al.
Human Immunology|June 1, 1992
Relative contribution of HLA-DQA and -DQB alleles to predisposition to insulin-dependent diabetes mellitusM J Giphart, B O Roep, J Drabbels, et al.
Tissue Antigens|August 24, 1999
HLA-DRB1*0403 is associated with dominant protection against IDDM in the general Dutch population and subjects with high-risk DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotypeB O Roep, R Schipper, W Verduyn, et al.
Tissue Antigens|September 1, 1995
A complete exon 2 sequence of the HLA-DPA1*02012 alleleL F Versluis, W Verduyn, A van der Zwan, et al.
Experimental and Clinical Immunogenetics|January 1, 1996
HLA-DRB1*04 high resolution typingA G Bouwens-Rombouts, W Verduyn, L F Versluis, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology in Drug Development|October 27, 2022
Safety, Pharmacokinetics, and Biomarkers of an Amorphous Solid Dispersion of Genistein, a Radioprotectant, in Healthy VolunteersArtur A Serebrenik, Carin W Verduyn, Michael D Kaytor
Human Immunology|February 1, 1995
Novel HLA-DPB1 alleles detected in the Ethiopian populationL F Versluis, W Verduyn, J Abdulkadir, et al.
Human Immunology|March 1, 1996
Sequence of HLA-DRB 1*1606 is incorrectJ D Anholts, A G Bouwens, W Verduyn, et al.
Human Immunology|April 1, 1992
T-cell recognition of class II products that result from the combined presence of two different HLA haplotypesW E Schroeijers, H S de Koster, W Verduyn, et al.
Human Immunology|June 1, 1994
Polymorphic gloves and histocompatibility testingJ J Drabbels, J Anholts, M J Giphart, et al.
Tissue Antigens|September 12, 2009
Thirty-six novel HLA alleles: 7 HLA-A, 11 HLA-B, 15 HLA-C and 3 HLA-DRB1J D H Anholts, M Aneq, H L J M Dirks, et al.
Human Immunology|June 1, 1992
Relative contribution of HLA-DQA and -DQB alleles to predisposition to insulin-dependent diabetes mellitusM J Giphart, B O Roep, J Drabbels, et al.
Tissue Antigens|August 24, 1999
HLA-DRB1*0403 is associated with dominant protection against IDDM in the general Dutch population and subjects with high-risk DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotypeB O Roep, R Schipper, W Verduyn, et al.
Tissue Antigens|September 1, 1995
A complete exon 2 sequence of the HLA-DPA1*02012 alleleL F Versluis, W Verduyn, A van der Zwan, et al.
Experimental and Clinical Immunogenetics|January 1, 1996
HLA-DRB1*04 high resolution typingA G Bouwens-Rombouts, W Verduyn, L F Versluis, et al.
Pageof 3